Cite

      et al.. “Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.” Lancet, vol. 6, no. 2, 2018, pp. 114–121. http://access.bl.uk/ark:/81055/vdc_100056608281.0x000004